These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38716318)

  • 21. Prevalence and Clinical Characteristics of Fabry Disease in Chinese Patients With Hypertrophic Cardiomyopathy.
    Xiao Y; Sun Y; Tian T; Wang TJ; Zhao RX; Zhang Y; Wang LP; Liu YX; Lu CX; Zhou XL; Yang WX
    Am J Med Sci; 2021 Sep; 362(3):260-267. PubMed ID: 34266644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort.
    Rubattu S; Bozzao C; Pennacchini E; Pagannone E; Musumeci BM; Piane M; Germani A; Savio C; Francia P; Volpe M; Autore C; Chessa L
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Clues for the Diagnosis of Nonsarcomeric Hypertrophic Cardiomyopathy (Phenocopies): Amyloidosis, Fabry Disease, and Mitochondrial Disease.
    Limongelli G; Masarone D; Verrengia M; Gravino R; Salerno G; Castelletti S; Rubino M; Marrazzo T; Pisani A; Cecchi F; Elliott PM; Pacileo G
    J Cardiovasc Echogr; 2018; 28(2):120-123. PubMed ID: 29911009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-mortem genetic investigation in sudden cardiac death victims: complete exon sequencing of forty genes using next-generation sequencing.
    Fadoni J; Santos A; Cainé L
    Int J Legal Med; 2022 Mar; 136(2):483-491. PubMed ID: 34984526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?
    Gustavsson S; Granåsen G; Grönlund C; Wiklund U; Mörner S; Henein M; Suhr OB; Lindqvist P
    Amyloid; 2015; 22(3):163-70. PubMed ID: 26104852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy.
    Jääskeläinen P; Vangipurapu J; Raivo J; Kuulasmaa T; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Vanninen S; Hämäläinen L; Melin J; Kokkonen J; Nieminen MS; ; Laakso M; Kuusisto J
    ESC Heart Fail; 2019 Apr; 6(2):436-445. PubMed ID: 30775854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy.
    Janin A; Chanavat V; Rollat-Farnier PA; Bardel C; Nguyen K; Chevalier P; Eicher JC; Faivre L; Piard J; Albert E; Nony S; Millat G
    Hum Mutat; 2020 Feb; 41(2):465-475. PubMed ID: 31730716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease.
    Melas M; Beltsios ET; Adamou A; Koumarelas K; McBride KL
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy.
    Janin A; Bessière F; Chauveau S; Chevalier P; Millat G
    Gene; 2018 Nov; 676():110-116. PubMed ID: 30012424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management.
    Licordari R; Trimarchi G; Teresi L; Restelli D; Lofrumento F; Perna A; Campisi M; de Gregorio C; Grimaldi P; Calabrò D; Costa F; Versace AG; Micari A; Aquaro GD; Di Bella G
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy.
    Maurizi N; Rella V; Fumagalli C; Salerno S; Castelletti S; Dagradi F; Torchio M; Marceca A; Meda M; Gasparini M; Boschi B; Girolami F; Parati G; Olivotto I; Crotti L; Cecchi F
    Int J Cardiol; 2020 Feb; 300():191-195. PubMed ID: 31371117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-Phenotype Correlations in 293 Russian Patients with Causal Fabry Disease Variants.
    Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Pakhomov A; Trufanova E; Alexeeva A; Sladkov D; Kuzenkova L; Asanov A; Fisenko A
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms.
    Gonzalez-Lopez E; Escobar-Lopez L; Obici L; Saturi G; Bezard M; Saith SE; AbouEzzeddine OF; Mussinelli R; Gagliardi C; Kharoubi M; Griffin JM; Dispenzieri A; Vilches S; Perlini S; Longhi S; Oghina S; Rivas A; Grogan M; Maurer MS; Damy T; Palladini G; Rapezzi C; Garcia-Pavia P
    JACC CardioOncol; 2022 Nov; 4(4):442-454. PubMed ID: 36444226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common presentation of rare diseases: Left ventricular hypertrophy and diastolic dysfunction.
    Linhart A; Cecchi F
    Int J Cardiol; 2018 Apr; 257():344-350. PubMed ID: 29506729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Genetics in Diagnosis and Management of Hypertrophic Cardiomyopathy: A Glimpse into the Future.
    Abbas MT; Baba Ali N; Farina JM; Mahmoud AK; Pereyra M; Scalia IG; Kamel MA; Barry T; Lester SJ; Cannan CR; Mital R; Wilansky S; Freeman WK; Chao CJ; Alsidawi S; Ayoub C; Arsanjani R
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Right ventricular involvement in transthyretin amyloidosis.
    Arvidsson S; Henein MY; Wikström G; Suhr OB; Lindqvist P
    Amyloid; 2018 Sep; 25(3):160-166. PubMed ID: 30193533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy.
    Bottillo I; D'Angelantonio D; Caputo V; Paiardini A; Lipari M; De Bernardo C; Giannarelli D; Pizzuti A; Majore S; Castori M; Zachara E; Re F; Grammatico P
    Gene; 2016 Feb; 577(2):227-35. PubMed ID: 26656175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mimics of Hypertrophic Cardiomyopathy - Diagnostic Clues to Aid Early Identification of Phenocopies.
    Sankaranarayanan R; J Fleming E; J Garratt C
    Arrhythm Electrophysiol Rev; 2013 Apr; 2(1):36-40. PubMed ID: 26835038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yield of Rare Variants Detected by Targeted Next-Generation Sequencing in a Cohort of Romanian Index Patients with Hypertrophic Cardiomyopathy.
    Micheu MM; Popa-Fotea NM; Oprescu N; Bogdan S; Dan M; Deaconu A; Dorobantu L; Gheorghe-Fronea O; Greavu M; Iorgulescu C; Scafa-Udriste A; Ticulescu R; Vatasescu RG; Dorobanțu M
    Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33297573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic Testing for Diagnosis of Hypertrophic Cardiomyopathy Mimics: Yield and Clinical Significance.
    Hoss S; Habib M; Silver J; Care M; Chan RH; Hanneman K; Morel CF; Iwanochko RM; Gollob MH; Rakowski H; Adler A
    Circ Genom Precis Med; 2020 Apr; 13(2):e002748. PubMed ID: 32150461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.